OKUR
OKUR
NASDAQ · Biotechnology

Onkure Therapeutics Inc-A

$2.50
+0.18 (+7.76%)
As of Feb 8, 2:21 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 5.03M 5.08M 4.69M
Net Income 1.10M 914.1K 814.2K
EPS
Profit Margin 21.9% 18.0% 17.4%
Rev Growth -9.3% +7.5% +3.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 14.23M 16.02M 17.11M
Total Equity 13.50M 13.01M 14.54M
D/E Ratio 1.05 1.23 1.18
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.45M 1.42M 1.49M
Free Cash Flow 1.19M 761.6K 738.1K